ArticlePloS one2014

DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.

Amandine Etcheverry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.